ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IDH Immunodiagnostic Systems Holdings Plc

378.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immunodiagnostic Systems Holdings Plc LSE:IDH London Ordinary Share GB00B01YZ052 ORD 2P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 378.00 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
  -
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 378.00 GBX

Immunodiagnostic Systems (IDH) Latest News

Real-Time news about Immunodiagnostic Systems Holdings Plc (London Stock Exchange): 0 recent articles

Immunodiagnostic Systems (IDH) Discussions and Chat

Immunodiagnostic Systems Forums and Chat

Date Time Title Posts
18/5/202104:10IDH with charts263
26/7/201805:16Immunodiagnostic Systems (IDH) One to Watch on Thursday -
20/6/201219:13IMMUNODIAGNOSTIC SYSTEMS HOLDINGS737
16/1/200908:38IDS - diagnostic testing kits for the clinical and research markets1

Add a New Thread

Immunodiagnostic Systems (IDH) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Immunodiagnostic Systems (IDH) Top Chat Posts

Top Posts
Posted at 17/5/2021 08:28 by cumnor
Nice surprise. Doubled my money here and sold. Incredible lack of bb activity on this share, largely down to mgmt inertia and presumably not too many PIs. Mgmt no doubt will have done well from this and no doubt keeping all the great news till this is a done deal but I am happy for one. Just shows how undervalued tech companies are in London when suddenly the market can put a cap on its value double what it was a few days prior-with no 'apparent' change in it's circumstances. Hold loads of shares in companies like BVC, VEC, Fab etc which I feel (and hope) are in a similar position but not sure why tech companies actually bother to list here.
Posted at 27/11/2020 14:43 by faz
Because this share is so hard to sell I have used today's rise (and some patience) to rid myself of my holding.
Posted at 27/11/2020 08:23 by bunz3
noce start ,also syme gradually starting to move up again Gradually ,hoping for a good strong day here at idh
Posted at 29/10/2020 10:35 by undervaluedassets
always the way ...

The winner these days is a always a whale.

which is the better investment:-

Amazon or Dixons Carphone?

Novacyt with a gazillion COVID test kits sold or IDH with a paltry £400,000 worth?

Not difficult to spot the winner

And the loser
Posted at 17/6/2020 16:04 by hedgehog 100
IDH is a former 20-bagger.

And it has plenty of facilities and cash to help address the COVID-19 testing shortage.

This could fuel another great period of share price performance.




IDH's current market cap. is £80.6M. at 280p, of which over a third is covered by its cash of about £28M.

And this is a nice market cap. for a growing business to achieve a stellar rating from. Because tracker funds are forced to buy in as the share price and market cap. rise.

This dynamic helped to fuel IDH's stellar rise to over £12 a share about a decade ago.
Posted at 17/6/2020 14:25 by hedgehog 100
It was a 'fake drop' early this morning: virtually all buys today, and at 280p the share price is now up on the day.

IDH has a lot going on regarding the massive COVID-19 opportunity, and the company promises to update the market re. any significant developments:

17/06/2020 07:00 UKREG Immunodiagnostic Systems Hldgs PLC Final Results

" ... 7. Outlook

... We are working to manufacture and commercialise CLIA and ELISA tests to detect SARS-CoV-2 antibodies, combining our resources and capabilities with partners who complement our skill set with their virology know-how. A summary of the opportunities we are working on is set out in Jaap's CEO report, and we will update the market via RNS if there is any significant news in this area. ...

Opportunities

We are currently in negotiations with a number of partners to manufacture and commercialise COVID-19 antibody test kits in both ELISA and CLIA formats.

We are currently working to manufacture and commercialise COVID-19 antibody test kits in both ELISA and CLIA formats, combining our resources and capabilities with partners who have knowledge in virology and infectious diseases. Our development partner, Technogenetics, has developed a COVID-19 IgG assay to detect SARS-CoV-2 antibodies. This quantitative automated assay which runs on the IDS-iSYS analyser, should be available for sale by IDS before the end of June, in Europe and distribution regions whose regulatory regime is based on the CE-mark.

In addition, we have agreed commercial terms with a UK based specialist medical diagnostics company to produce components of their COVID-19 ELISA manual assay. Finally, we are working with a number of partners with expertise in virology and immunology to provide a route to market for ELISA-based COVID-19 assays, utilising our direct sales organisation as well as our extensive distribution network. ..."




I think that we can expect some very exciting IDH newsflow over the summer, which should help drive the share price to much higher levels.
Posted at 12/6/2020 08:00 by farukequity
whoever is running PR & Investor Relations department in this business should be fired on the spot. keeping things under wraps is not how you create shareholder value in the 21st century. imagine if they issued an announcement initially they are working on a quantitative antibody test & leveraging all the unique advantages of their underlying business - the share price would be 2-3x higher before today's announcement already.

hope they are doing Zoom calls with media & institutions 24 f...ing 7 right now to make people aware of what they have.

for all of the small retail investors like yours truly, at least they are at the top of today's leader boards, so thousands of people will be looking at this company and scratching their heads just like me.

these guys have the final product, distribution network and unit economics all ready - and the explosive share price rise is just beginning
Posted at 12/6/2020 07:33 by 74tom
It’s not at a higher valuation because the company appears dire at communicating, and the share is horrendously illiquid. Interested to see where the share price is by this afternoon...
Posted at 22/4/2020 14:44 by hedgehog 100
IDH is a former 20-bagger.

And it has plenty of facilities and cash to help address the COVID-19 testing shortage.

This could fuel another great period of share price performance.
Posted at 22/4/2020 14:16 by hedgehog 100
Speaking of Omega Diagnostics, its share price has been doing rather well recently, multibagging from 7.625p at the start of this month to its current share price of 31p.

Fueled by announcements that it is to manufacture COVID-19 tests.

And IDH looks like it will also be entering into such agreements shortly, judging from its recent trading update.

But the market doesn't seem to have picked up on this yet.

Probably because IDH is currently 'under the radar screen' of most investors, and the RNS was released after close on Friday (17th. April).


17/04/2020 16:35 UKREG Immunodiagnostic Systems Hldgs PLC FY20 Trading Update

" ... Cash position

Closing cash and cash equivalents were GBP27.6m at 31 March 2020 (31 March 2019: GBP27.7m).

... Looking forward

So far in April 2020 we have seen a reduction in revenue versus the same period last year, caused by a reduction in routine medical testing in hospitals and laboratories as their focus has been on COVID-19 treatment and testing. IDS intend to take appropriate action, including utilising the various schemes available from governments to provide business support, to minimise our costs during this period of uncertainty. From a liquidity perspective, IDS is in a very strong position with cash holdings of almost GBP28m.

We are offering our production facilities, and sales network, to several new and existing partners who are in the process of developing COVID-19 test kits. ... "
Immunodiagnostic Systems share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock